Preventing transmission of multidrug-resistant bacteria in health care settings: A tale of two guidelines

Clinical Infectious Diseases

Volumn 42, Issue 6, 2006, Pages 828-835

  Strausbaugh, Larry J ^a,b   Siegel, Jane D ^c,d   Weinstein, Robert A ^e,f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CHILDREN S MEDICAL CENTER   (United States)

^e Jr Hospital of Cook County   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; DISEASE TRANSMISSION; EVIDENCE BASED MEDICINE; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; HOSPITALS; HUMANS; INFECTION CONTROL; PATIENT ISOLATION; PRACTICE GUIDELINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33644836125     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/500408     Document Type: Review

References (43)

1. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.
2. Siegel J, Strausbaugh L, Jackson M, Rhinehart E, Chiarello L, Healthcare Practices Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Draft guideline for isolation precautions: preventing transmission of infectious agents in Healthcare settings. June, 2004: http://www.premierinc.com/all/safety/resources/guidelines/cdc_guidelines.jsp. Accessed 11 September 2005.
3. Centers for Disease Control and Prevention. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-85.
4. Trick WE, Weinstein RA, DeMarais PL, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001; 49:270-6.
5. Loeb MB, Craven S, McGeer AJ, et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol 2003; 157:40-7.
6. Centers for Disease Control and Prevention. Brief report: vancomycin-resistant Staphylococcus aureus - New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:322-3.
7. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:1041-4.
8. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-44.
9. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53:1374-84.
10. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39:1460-6.
11. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998;338:1861-8.
12. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-74.
13. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-5.
14. Cosgrove SE, Kaye KS, Eliopoulous GM, Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002; 162:185-90.
15. Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003; 24:690-8.
16. Sunenshine RH, Liedtke LA, Fridkin SK, Strausbaugh LJ. Management of inpatients colonized or infected with antimicrobial resistant bacteria in the United States. Infect Control Hosp Epidemiol 2005; 26:138-43.
17. Harris AD, Lautenbach E, Perencevich E. Systematic review of quasi-experimental study designs in the field of infection control and antibiotic resistance. Clin Infect Dis 2005; 41:77-82.
18. Cooper BS, Stone SP, Kibbler CC, et al. Isolation measures in the hospital management of methitillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004; 329:1-8.
19. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines). J Am Coll Cardiol 2001;37:2239i-lxvi.
20. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981; 70:449-54.
21. ClinicalTrials.gov. Hand hygiene; strategies to reduce transmission of antimicrobial resistant bacteria in intensive care units. Available at: http://clinicaltrials.gov/ct/show/NCT00100386forder = 1. Accessed 29 September 2005.
22. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 2000; 21:575-82.
23. Lucet JC, Deere D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-preducing Enterobacteriaceae in a university hospital. Clin Infect Dis 1999; 29:1411-8.
24. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16:686-96.
25. Rosdahl VT, Knudsen AM. The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991; 12:83-8.
26. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18:461-6.
27. Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169-75.
28. Puzniak LA, Gillespie KN, Leet T, Kollef M, Mundy LM. A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? Infect Control Hosp Epidemiol 2004;25:418-24.
29. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
30. Cooper BS, Stone SP, Kibbler CC, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modeling. Health Technol Assess 2003; 7:1-194.
31. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-20.
32. Eggimann P, Hugonnet S, Sax H, Harbarth S, Chevrolet JC, Pittet D. Long-term reduction of vascular access-associated bloodstream infection. Ann Intern Med 2005; 142:875-6.
33. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 2002;51(RR-10):1-26.
34. Centers for Disease Control and Prevention. Reduction in central line-associated bloodstream infections among patients in intensive care units - Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1013-6.
35. Jochimsen EM, Fish L, Manning K, et al. Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 1999; 20:106-9.
36. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999; 131:269-72.
37. Eveillard M, Eb F, Tramier B, et al. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. J Hosp Infect 2001; 47:116-24.
38. Afif W, Huor P, Brassard P, Loo VG. Compliance with methicillin-resistant Staphylococcus aureus precautions in a teaching hospital. Am J Infect Control 2002; 30:430-3.
39. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427-33.
40. Nicolle LE, Dyck B, Thompson G, et al. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Manitoba Chapter of CHICA-Canada. Infect Control Hosp Epidemiol 1999; 20:202-5.
41. Kirkland KB, Weinstein JM. Adverse effects of contact isolation. Lancet 1999; 354:1177-8.
42. Saint S, Higgins LA, Nallamothu BK, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003; 31:354-6.
43. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290:1899-905.